片语

polylactide copolymer聚乳酸共聚物

polylactide macromonomer聚乳酸大分子单体

polylactide microspheres聚乳酸微球

polylactide fiber聚丙交酯纤维

polylactide acid聚乳酸

polylactide acide聚乳酸

reinforced polylactide增强聚乳酸

polylactide pla聚乳酸

英汉例句

• micropipette aspiring system was selected to test the adhesion property of wistar rat osteoblasts on polylactide (pla) and maleic anhydride modified polylactide (mpla) made in our laboratory.

  采用微管吸吮装置对大鼠成骨细胞，在聚乳酸和马来酸酐改性聚乳酸材料表面的粘附性能进行了研究。

• the carbon fiber-reinforced polylactide (c/pla) was prepared for bone fracture fixation, and the carbon fiber was treated by surface soakage with concentrated nitric acid.

  制备了碳纤维增强聚乳酸（c/pla）骨折内固定材料，对碳纤维进行了浓硝酸表面处理。

• the influence of melt polycondensation and solvent refluxing methods of lactide polymerization and chain extension agents on relative molecular weight of polylactide was studied.

  研究了乳酸熔融缩聚和溶剂回流脱水缩聚两种聚合方法及几种扩链剂对乳酸聚合物相对分子质量的影响。

• in this paper, performance features of polylactide fiber and its applications in fabric, nonwoven, apparel, household, hygiene and medical markets are introduced.

  介绍了生物可降解纤维—— 聚乳酸纤维的性能特征及其在混纺、非织造布、服装、装饰、医疗等领域的应用前景。

• the scanning electron micrograph and dsc data show that an excessive amount of tpp crystallization was on the surfaces of polylactide fibers and the tensile strength was cut down by 70%.

  扫描电镜观察和dsc测试表明，此时的纤维表面上出现过量的tpp结晶，拉伸强力下降了70%。

• polylactide had good compatibility, degradable and absorption, and was widely used to the medicine cover, degeneration medicine, absorbing operation thread, and internal fixation of bone fracture.

  聚乳酸具有良好的生物相容性、降解性和可吸收性，已经广泛用于医药包覆、缓释药物、手术缝合线、骨折固定材料。

• after comparing the property of polylactide fiber to that of pet fibers and natural fibers, it discussed the applications of polylactide fiber in medical, fabrics and non-woven fabrics.

  比较了聚乳酸纤维与涤纶等合成纤维及真丝等天然纤维的物理性能指标。最后，介绍了聚乳酸纤维在医药、织物和非织造布方面的应用。

• it described the spinning method including solution-spinning and melt-spinning and process of melt-spinning of polylactide and companies manufacturing polylactide fiber in the world.

  介绍了聚乳酸纤维的纺丝方法、聚乳酸熔融纺丝工艺流程及目前国内外聚乳酸纤维的生产、开发情况。

• raw bamboo fibers reinforced polylactide biodegradable material was prepared by means of non-woven method and moulding pressing technology.

  以竹原纤维、聚乳酸为原料，采用非织造结合模压成型工艺制备了完全可降解材料。

• the structural and functional properties of hydroxyapatite, polylactide and polyglycolide were reviewed in this paper.

  阐述了羟基磷灰石、聚乳酸和聚乙醇酸各自的结构性能特点；

• with the introduction of electrospinning of polylactide containing different drugs or antibacterial nanoparticles and release studies. analysis the effect and cause of controlled release.

  介绍了加入不同的药物或抗菌纳米微粒的聚乳酸基的静电纺丝及其释药性能，并对其缓释效果及其原因进行分析。

• aim to evaluate the immunogenicity of tetanus toxoid (tt) encapsulated in biodegradable polymer microspheres composed of polylactide (pla).

  目的研究破伤风类毒素聚乳酸微球在动物体内的免疫效果及影响因素。

• polylactide and its copolymers are polymer materials that can be degraded by organisms and have good biocompatibility.

  聚乳酸及其共聚物是具有优良的生物相容性和可生物降解的高分子材料，无毒，可吸收。

• the application of polylactide in biomedical field was introduced, such as medicine slow release, bone screw fixation, surgical suture, ophthalmic material. and the prospects were outlooked.

  介绍了聚乳酸在生物医学工程领域的应用，如药物缓释材料、骨固定材料、手术缝合线、眼科材料等，对其在生物医学领域的研究前景作了展望。

• objective: study the toxic effect and release efficiency with ibuprofen polylactide microspheres implantation in subarachnoid.

  目的研究布洛芬聚乳酸微球的在颅内蛛网膜下腔应用的毒副作用以及体内释放效率。

• carbon fiber-reinforced polylactide (c/pla) composite used for bone fracture fixation was prepared, and the change of mechanical performance was investigated during in vitro degradation.

  制备了碳纤维增强聚乳酸（c/ pla）骨折内固定复合材料，研究了体外降解过程中其力学性能的变化。

• latest research progress of microspheres containing drugs used three commonly biodegradable materials which were gelatin, chitosan and polylactide was summarized.

  本文主要综述了明胶、壳聚糖、 聚乳酸这三种常用的可生物降解的载药微球的研究进展。

• the invention also relates to a polymerisation device for producing polylactide and to a method for recycling process steam produced during the production of polylactide.

  本发明还涉及一种生产聚丙交酯的聚合装置和再循环在生产聚丙交酯中产生的工艺蒸汽的方法。

• conclusion: the ibuprofen polylactide microspheres could be used as a local slow release drug in cranial under a certain concentration.

  结论布洛芬聚乳酸微球在一定浓度下可以作为一种局部缓释药物应用于颅内。

• objective: to study on in vitro release of tetanus toxoid contained in polylactide microspheres and the influence of additives on the drug release.

  目的：研究破伤风类毒素聚乳酸微球的体外释放规律，考察附加剂对药物释放的影响。